학술논문

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)
Document Type
Article
Source
In: Leukemia. (Leukemia, May 2021, 35(5):1392-1404)
Subject
Language
English
ISSN
14765551
08876924